Showing results (481-490 of 881) with videos related to

Sort By:
Pageof 89
Open Forum Infectious Diseases|January 31, 2019
Correlation Between Tenofovir Drug Levels and the Renal Biomarkers RBP-4 and ß2M in the ION-4 Study CohortAustin Chan, Lawrence Park, Lauren F Collins, et al.
Toxicology|June 24, 2018
Ultrastructural and biochemical features of cerebral microvessels of adult rat subjected to a low dose of silver nanoparticlesBeata Dąbrowska-Bouta, Grzegorz Sulkowski, Małgorzata Frontczak-Baniewicz, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|January 22, 2015
Adenoid basal carcinoma-like tumor combined with invasive squamous cell carcinoma foci of uterine cervix - a case report of 55-year-old woman with literature reviewAndrzej Wincewicz, Piotr Lewitowicz, Sławka Urbaniak-Wąsik, et al.
Hepatology Communications|April 21, 2025
Health economic outcomes of a minimal monitoring approach to providing HCV therapyBenjamin P Linas, Michelle Weitz, Tannishtha Pramanick, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapyMark Sulkowski, Teresa Wright, Stephen Rossi, et al.
Annals of Internal Medicine|October 18, 2000
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United StatesS H Mehta, F L Brancati, M S Sulkowski, et al.
The Lancet. HIV|December 25, 2019
Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIVRobert C Bollinger, Chloe L Thio, Mark S Sulkowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Efficacy and Safety of Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C in Persons With Sickle Cell DiseaseJuhi Moon, Robert H Hyland, Fangqiu Zhang, et al.
Pageof 89